Rocket Pharmaceuticals Is Maintained at Buy by Canaccord Genuity
Rocket Pharmaceuticals Price Target Maintained With a $38.00/Share by Canaccord Genuity
CCORF Maintains Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Maintains Target Price $38
A Quick Look at Today's Ratings for Rocket Pharmaceuticals(RCKT.US), With a Forecast Between $38 to $53
On Sep 18, major Wall Street analysts update their ratings for $Rocket Pharmaceuticals(RCKT.US)$, with price targets ranging from $38 to $53.Morgan Stanley analyst Michael Ulz maintains with a buy
Small U.S. Stocks Move Upward; Rocket Pharmaceuticals Leads Increases
Rocket Pharma Gains on Trial Update for Gene Therapy
Rocket Pharmaceuticals Shares Are Trading Higher After the Company Announced That All Patients Have Bene Enrolled in the Global Phase 2 Clinical Trial Evaluating RP-A501 to Treat Male Patients With Danon Disease.
Needham Reiterates Buy on Rocket Pharmaceuticals, Maintains $52 Price Target
Rocket Pharmaceuticals Analyst Ratings
Buy Rating for Rocket Pharmaceuticals Amid Positive Projections for RP-A501 Danon Disease Study
Express News | Rocket Pharmaceuticals Announces Completion of Enrollment in Phase 2 Pivotal Trial of Rp-a501 for the Treatment of Danon Disease
Rocket Pharmaceuticals Announces Completion of Enrollment in Phase 2 Pivotal Trial of RP-A501 for the Treatment of Danon Disease
Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of Directors
Express News | Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.d., Ph.d., to Board of Directors
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday
Express News | Rocket Pharmaceuticals Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing
Rocket Pharmaceuticals (RCKT) Receives a Buy From Bank of America Securities
Possible Bearish Signals With Rocket Pharmaceuticals Insiders Disposing Stock
Analysts Conflicted on These Healthcare Names: Henry Schein (HSIC), Zymeworks (ZYME) and Rocket Pharmaceuticals (RCKT)